Welcome to your Still’s disease resource library!
Here you can find peer-reviewed journal articles on the many facets of Still’s disease. As authors of evidence-based blogs, we utilize some of these journal articles as citations. We also want you as patients, family or support members of patients and providers to utilize this library!
To ensure Still’s disease patients and their providers are armed with the science behind their disease, these resources are all open access except where mentioned. We have provided those housed and accessible for free on Pubmed Central, Unpaywall, DOAJ, and a myriad of other free and legal resources that make science more open and accessible.
In the event you are unable to get a full copy of an article, we strongly encourage you to ask your provider for a copy, as they generally have resources to access medical literature. Most providers will be happy to use and share evidence-based information for your care, and when you ask them for a study, you start to develop a deeper patient-provider partnership based in a common understanding of your disease.
See our thoughts in our related blog posts:
Defining Adult Onset Still’s Disease
Comprehensive articles covering all aspects of SJIA and AOSD, including history, clinical presentation, and diagnosis. Ideal introductory texts.
- Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches
Note: Not open access.
We covered Still’s disease diagnosis, and the problem with current criteria in our blog:
Diagnosing Still’s disease
In depth articles about the diagnosis of Still’s disease.
- International League of Associations for Rheumatology Classification of Juvenile Idiopathic Arthritis: Second Revision, Edmonton, 2001
Note: Includes criteria for SJIA.
- Preliminary Criteria for Classification of Adult Still’s Disease
Note: Also known as the Yamaguchi Criteria, has been used in pediatrics as well.
We cover the most common Still’s disease treatments on our site:
Treating Still’s disease and it’s complications
- Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019
- Adult onset Still’s disease—The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review)
- Targeting cytokines to treat autoinflammatory diseases
Note: Not open access
Macrophage Activation Syndrome
See our post about MAS:
Immune-Overdrive: Cytokine Storms & COVID-19
Macrophage Activation Syndrome or MAS is a life threatening complication long associated with Still’s disease.
The evidence that SJIA and AOSD are the same disease as a continuum of pediatric and adult onsets.
- Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still’s disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity
- Cytokine profile in adult-onset Still’s disease: Comparison with systemic juvenile idiopathic arthritis
Looking for other resources?
Just want to talk to someone about all this science?
Send us a message!